AbbVie Inc. (ABBV) Balance Sheet
As of 2026-06-30 (10-Q), AbbVie Inc. (ABBV) reported total assets of $135.1B and shareholders' equity of -$5.9B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.6B. Long-term debt: $62.5B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ABBVAbbVie Inc.Follow ABBV — free
—
Price chart with a free account
- Market cap
- 504.8B
- P/E TTM
- 80.7
- Dividend yield
- 2.4%
- 52-week
- —
- Next earnings
- 30 Oct, in 6 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.60 | 8.35 | 8.40 | 5.10 | 9.30 | 7.29 | 39.92 | 8.45 | 9.75 | 9.20 | 12.81 | 5.52 | 5.23 | 6.57 | |
| Short-term investments | 0.30 | 0.03 | 0.01 | 1.32 | 0.49 | 0.77 | 0.00 | 0.03 | 0.08 | 0.03 | 0.00 | 0.03 | 0.03 | — | |
| Receivables | 3.85 | 3.74 | 4.73 | 4.76 | 5.09 | 5.38 | 5.43 | 8.82 | 9.98 | 11.25 | 11.16 | 10.92 | 12.59 | 13.82 | |
| Inventory | 1.15 | 1.12 | 1.72 | 1.44 | 1.61 | 1.61 | 1.81 | 3.31 | 3.13 | 3.58 | 4.10 | 4.18 | 4.95 | 5.13 | |
| Current assets | 17.85 | 16.08 | 16.31 | 16.19 | 21.22 | 16.95 | 49.52 | 24.17 | 27.93 | 28.46 | 33.00 | 25.58 | 29.06 | 33.67 | |
| Total assets | 29.20 | 27.51 | 53.05 | 66.10 | 70.79 | 59.35 | 89.12 | 150.57 | 146.53 | 138.81 | 134.71 | 135.16 | 133.96 | 135.12 | |
| Current liabilities | 6.88 | 11.39 | 10.89 | 9.78 | 16.64 | 17.24 | 15.59 | 28.66 | 35.19 | 29.54 | 37.84 | 38.75 | 43.29 | 41.64 | |
| Long-term debt | 14.29 | 10.54 | 29.24 | 36.44 | 30.95 | 35.00 | 62.98 | 77.55 | 64.19 | 59.14 | 52.19 | 60.34 | 58.94 | 62.48 | |
| Short-term debt | 0.02 | 4.01 | 2.03 | 0.03 | 6.02 | 1.61 | 3.75 | 8.47 | 12.48 | 4.14 | 7.19 | 6.80 | 6.06 | 8.34 | |
| Shareholders' equity | 4.49 | 1.74 | 3.95 | 4.64 | 5.10 | -8.45 | -8.17 | 13.08 | 15.41 | 17.25 | 10.36 | 3.33 | -3.27 | -5.94 |
USD billions · SEC XBRL
AbbVie Inc. — questions
- How much cash does AbbVie Inc. have?
- $6.6B in cash and cash equivalents as of 2026-06-30.
- How much debt does AbbVie Inc. have?
- $62.5B of long-term debt and $8.3B due within a year as of 2026-06-30.
- What are AbbVie Inc.'s total assets?
- $135.1B as of 2026-06-30.
- What is AbbVie Inc.'s shareholders' equity?
- -$5.9B as of 2026-06-30.
Every figure on this page comes from AbbVie Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.